Outcomes Associated With Neutropenia and Lymphopenia in Epidermal Necrolysis: A Single-Center Retrospective Study of 147 Patients.
暂无分享,去创建一个
[1] Leo L. Wang,et al. Prevalence of Leukopenia and Associated Outcomes in Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis. , 2022, JAMA dermatology.
[2] P. Wolkenstein,et al. Epidermal necrolysis: characterization of different phenotypes using an unsupervised clustering analysis , 2022, The British journal of dermatology.
[3] F. Cosset,et al. Massive clonal expansion of polycytotoxic skin and blood CD8+ T cells in patients with toxic epidermal necrolysis patients , 2021, Science Advances.
[4] P. Wolkenstein,et al. Trends in mortality rates for Stevens–Johnson syndrome and toxic epidermal necrolysis: experience of a single centre in France between 1997 and 2017 , 2019, The British journal of dermatology.
[5] J. Roujeau,et al. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. , 2000, The Journal of investigative dermatology.
[6] J. Roujeau,et al. Lymphopenia and abnormal balance of T-lymphocyte subpopulations in toxic epidermal necrolysis , 1984, Archives of Dermatological Research.